doi: 10.2217/pgs.10.15.
Pharmacogenomics and bioinformatics: PharmGKB
Affiliations
- PMID:20350130
- PMCID: PMC3098752
- DOI: 10.2217/pgs.10.15
Item in Clipboard
Pharmacogenomics and bioinformatics: PharmGKB
Caroline F Thorn et al. Pharmacogenomics.2010 Apr.
Display options
Format
Display options
Format
Abstract
The NIH initiated the PharmGKB in April 2000. The primary mission was to create a repository of primary data, tools to track associations between genes and drugs, and to catalog the location and frequency of genetic variations known to impact drug response. Over the past 10 years, new technologies have shifted research from candidate gene pharmacogenetics to phenotype-based pharmacogenomics with a consequent explosion of data. PharmGKB has refocused on curating knowledge rather than housing primary genotype and phenotype data, and now, captures more complex relationships between genes, variants, drugs, diseases and pathways. Going forward, the challenges are to provide the tools and knowledge to plan and interpret genome-wide pharmacogenomics studies, predict gene-drug relationships based on shared mechanisms and support data-sharing consortia investigating clinical applications of pharmacogenomics.
Figures
The gene search box returns links to genes associated with the search term. Example queries can be viewed and include: search by gene symbol, drug, disease, drug/disease combination, Entrez Gene ID, PubMed ID and protein name [102].
Similar articles
- PharmGKB: the Pharmacogenomics Knowledge Base.Thorn CF, Klein TE, Altman RB.Thorn CF, et al.Methods Mol Biol. 2013;1015:311-20. doi: 10.1007/978-1-62703-435-7_20.Methods Mol Biol. 2013.PMID:23824865Free PMC article.
- The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge.Hernandez-Boussard T, Whirl-Carrillo M, Hebert JM, Gong L, Owen R, Gong M, Gor W, Liu F, Truong C, Whaley R, Woon M, Zhou T, Altman RB, Klein TE.Hernandez-Boussard T, et al.Nucleic Acids Res. 2008 Jan;36(Database issue):D913-8. doi: 10.1093/nar/gkm1009. Epub 2007 Nov 21.Nucleic Acids Res. 2008.PMID:18032438Free PMC article.
- PharmGKB: understanding the effects of individual genetic variants.Sangkuhl K, Berlin DS, Altman RB, Klein TE.Sangkuhl K, et al.Drug Metab Rev. 2008;40(4):539-51. doi: 10.1080/03602530802413338.Drug Metab Rev. 2008.PMID:18949600Free PMC article.
- Pharmacogenomics knowledge for personalized medicine.Whirl-Carrillo M, McDonagh EM, Hebert JM, Gong L, Sangkuhl K, Thorn CF, Altman RB, Klein TE.Whirl-Carrillo M, et al.Clin Pharmacol Ther. 2012 Oct;92(4):414-7. doi: 10.1038/clpt.2012.96.Clin Pharmacol Ther. 2012.PMID:22992668Free PMC article.Review.
- From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource.McDonagh EM, Whirl-Carrillo M, Garten Y, Altman RB, Klein TE.McDonagh EM, et al.Biomark Med. 2011 Dec;5(6):795-806. doi: 10.2217/bmm.11.94.Biomark Med. 2011.PMID:22103613Free PMC article.Review.
Cited by
- The Association between Gene-Environment Interactions and Diseases Involving the Human GST Superfamily with SNP Variants.Hollman AL, Tchounwou PB, Huang HC.Hollman AL, et al.Int J Environ Res Public Health. 2016 Mar 29;13(4):379. doi: 10.3390/ijerph13040379.Int J Environ Res Public Health. 2016.PMID:27043589Free PMC article.Review.
- Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available.Samwald M, Xu H, Blagec K, Empey PE, Malone DC, Ahmed SM, Ryan P, Hofer S, Boyce RD.Samwald M, et al.PLoS One. 2016 Oct 20;11(10):e0164972. doi: 10.1371/journal.pone.0164972. eCollection 2016.PLoS One. 2016.PMID:27764192Free PMC article.
- A Multi-scale Computational Platform to Mechanistically Assess the Effect of Genetic Variation on Drug Responses in Human Erythrocyte Metabolism.Mih N, Brunk E, Bordbar A, Palsson BO.Mih N, et al.PLoS Comput Biol. 2016 Jul 28;12(7):e1005039. doi: 10.1371/journal.pcbi.1005039. eCollection 2016 Jul.PLoS Comput Biol. 2016.PMID:27467583Free PMC article.
- PAGER: constructing PAGs and new PAG-PAG relationships for network biology.Yue Z, Kshirsagar MM, Nguyen T, Suphavilai C, Neylon MT, Zhu L, Ratliff T, Chen JY.Yue Z, et al.Bioinformatics. 2015 Jun 15;31(12):i250-7. doi: 10.1093/bioinformatics/btv265.Bioinformatics. 2015.PMID:26072489Free PMC article.
- Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review.Csermely P, Korcsmáros T, Kiss HJ, London G, Nussinov R.Csermely P, et al.Pharmacol Ther. 2013 Jun;138(3):333-408. doi: 10.1016/j.pharmthera.2013.01.016. Epub 2013 Feb 4.Pharmacol Ther. 2013.PMID:23384594Free PMC article.Review.
References
Bibliography
- Klein TE, Chang JT, Cho MK, et al. Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Pharmacogenomics J. 2001;1(3):167–170. - PubMed
- Lin Z, Owen AB, Altman RB. Genetics. Genomic research and human subject privacy. Science. 2004;305(5681):183. - PubMed
- Luciano JS. PAX of mind for pathway researchers. Drug Discov Today. 2005;10(13):937–942. - PubMed
Websites
- DNA Twist.http://DNATwist.org.
- PharmGKB.www.pharmgkb.org.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous